FN Clarivate Analytics Web of Science
VR 1.0
PT J
DE human-robot interaction; natural language processing; spoken dialogue
   systems; conversational agents; socially assistive robotics
ID SPEECH RECOGNITION; LANGUAGE; INFORMATION; COMMUNICATION; INTERFACE;
   MACHINE
ER

PT J
DE conversational assistant; conversational interface; dialogue system;
   medical error; patient safety
ID RANDOMIZED CONTROLLED-TRIAL; HEALTH DIALOG; MENTAL-HEALTH; COMPUTER;
   EXERCISE; TAXONOMY; TALKING; AGENTS
ER

PT J
DE artificial intelligence [Mesh]; medical informatics [Mesh];
   conversational agent; dialogue system
ID SPOKEN DIALOGUE; UNINTENDED CONSEQUENCES; VIRTUAL HUMAN; MACHINE;
   INTERVENTIONS; COMMUNICATION; RECOGNITION; TECHNOLOGY; INTERFACE;
   LANGUAGE
ER

PT J
ER

PT J
ID BENEFITS
ER

PT J
ID RECOMMENDER SYSTEMS; OUR-LIVES; TRENDS
ER

PT J
DE Air quality; Airways; Eyes; Humidity; Influenza virus; Sensory
   irritation; Sleep quality
ID LOW RELATIVE-HUMIDITY; HEATED BREATHING TUBE; TEAR FILM STABILITY; DRY
   EYE DISEASE; CONTROLLED-ENVIRONMENT CHAMBER; AIRBORNE SENSORY IRRITANTS;
   OFFICE WORKERS; OCULAR SURFACE; OF-LIFE; INTERCONTINENTAL FLIGHTS
ER

PT J
ID VAGUS NERVE-STIMULATION; CONSENSUS APPROACH; EPILEPSY; CHILDREN;
   CLOBAZAM; TOLERABILITY; EXPERIENCE; RUFINAMIDE; DIAGNOSIS; EFFICACY
ER

PT J
ID TRIAL; OSTEONECROSIS; SURVIVAL; CELLS; JAW; BISPHOSPHONATES; MODEL;
   RISK; IX
ER

PT J
DE Dialog systems; Multi-domain; Spoken interaction; Human-machine
   interaction; Neural networks; Statistical methodologies
ID SPOKEN DIALOG SYSTEMS; HYBRID APPROACH; MANAGEMENT; EXAMPLES;
   CLASSIFICATION; WEB
ER

PT B
DE Conversational agents; mental models; explainable intelligent user
   interfaces
ER

PT B
ER

PT B
DE Multimodal output; natural language generation; autonomous systems;
   situation awareness; cognitive styles
ID OBJECT; STYLE
ER

PT B
DE Conversational agents; Chatbots; Generative framework; Closed domain
ER

PT B
DE Chatbot; Homomorphic Redaction; Context Digression
ER

PT B
DE Form; conversational agent; interface
ER

PT B
DE conversational agents; reminiscence; system requirements
ID PEOPLE; MEMORY; GUIDE
ER

PT B
DE Conversational search; Multimedia; Recommender systems; Collaborative
   filtering
ER

PT S
ER

PT B
DE Instant Messenger; Chatbot; Conversational User Interface; Stock
   Investment; Decision Making
ID DIALOGUE SYSTEMS; AGENTS; ELIZA
ER

PT S
DE Domain knowledge acquisition; Dialog structure annotation;
   Conversational interfaces; Human-machine interaction; Spoken interaction
ID SEGMENTATION
ER

PT S
DE Mobile learning; Conversational interfaces; Computer-supported
   education; Multimodal interaction
ID LANGUAGE; SYSTEMS; DIALOG
ER

PT J
DE algorithms; journalism; metajournalistic discourse; social media
ID METAJOURNALISTIC DISCOURSE
ER

PT J
DE collaboration; consumption; management; accommodation sector; online
   reputation; online reviews
ID WORD-OF-MOUTH; CONSUMER-GENERATED MEDIA; HOTEL REVIEWS; TRIPADVISOR;
   REPUTATION; BEHAVIOR; IMPACT; TRUST; VOICE; EWOM
ER

PT J
ID COGNITIVE-BEHAVIORAL THERAPY; SYMPTOM RATING-SCALES; ASSISTED THERAPY;
   SCHIZOPHRENIA; VOICES; INTERVENTIONS; METAANALYSIS; OMNIPOTENCE;
   DIMENSIONS; DEPRESSION
ER

PT J
ID QUALITY-OF-LIFE; PRIMARY ANTIBODY DEFICIENCIES; IGG SELF-INFUSIONS;
   MUSCLE STRENGTH; THERAPY; POLYRADICULONEUROPATHY; CIDP; HOME; ICE;
   SATISFACTION
ER

PT J
DE communicative agents; spoken language processing; hierarchical control;
   intentional speech synthesis; autonomous social agents; mismatched
   priors
ID HIDDEN MARKOV-MODELS; SPEECH; PERCEPTION; LANGUAGE; COMPREHENSION;
   PREDICTIONS; REDUCTION; BEHAVIOR; PROGRESS; BRAIN
ER

PT J
DE Controlled natural language (CNL); conversational interface;
   human-computer collaboration (HCC); human-machine interaction (HMI);
   tactical intelligence
ID MACHINE
ER

PT J
DE Older adults; Social isolation; Digital pet; Embodied conversational
   agent; Information and communication technology
ID SOCIAL-ISOLATION; TECHNOLOGY; HOME
ER

PT J
DE Cancellability; Grice; Pragmatics
ID CONVERSATIONAL IMPLICATURES; DISTINCTION; STANLEY; SZABO; GRICE
ER

PT J
ID INSULIN-TREATMENT; SGLT2 INHIBITORS; MELLITUS; GLUCOSE; LIRAGLUTIDE;
   OBESITY; KIDNEY; METAANALYSIS; ASSOCIATION; MORTALITY
ER

PT J
ID SURVIVAL; CHEMOTHERAPY
ER

PT J
DE Natural language interface; Digital assistant; Social AIs; Driving;
   Simulation; Wizard-of-Oz
ER

PT J
ID INTIMA-MEDIA THICKNESS; GLYCEMIC CONTROL; ENDOTHELIAL FUNCTION; OF-VIEW;
   COMPLICATIONS; PROGRESSION; DEFICIENCY; MORTALITY; DISEASE; DESIGN
ER

PT J
DE computer supported education; conversational agents; mobile learning;
   m-learning; adaptive learning; multimodal interaction; spoken
   interaction; mobile devices; android; intelligent assistants; university
   digital libraries
ID SPOKEN DIALOG SYSTEMS; HIGHER-EDUCATION; MOBILE; LANGUAGE; GAMIFICATION;
   ENVIRONMENTS; ADOPTION; PERSPECTIVE; TECHNOLOGY; MANAGEMENT
ER

PT J
ID DOCETAXEL; PERTUZUMAB; GUIDELINES; RECEPTOR
ER

PT J
ID GENE-RELATED PEPTIDE; QUALITY-OF-LIFE; EPISODIC MIGRAINE; PLASMA-LEVELS;
   CGRP; ONABOTULINUMTOXINA; ATTACKS; TOLERABILITY; MULTICENTER;
   TELCAGEPANT
ER

PT J
ID GLUCAGON-LIKE PEPTIDE-1; DIPEPTIDYL PEPTIDASE-4 INHIBITORS; GLP-1
   RECEPTOR AGONISTS; WEIGHT MANAGEMENT; GLUCOSE CONTROL; BLOOD-PRESSURE;
   RISK-FACTORS; ASSOCIATION; MELLITUS; PLACEBO
ER

PT J
ID GLP-1 ANALOG LIRAGLUTIDE; WEIGHT-LOSS; METFORMIN; GLUCOSE; ASSOCIATION;
   METABOLISM; PERSPECTIVES; STATEMENT; MELLITUS; DISEASE
ER

PT J
DE H.5.2 user interfaces; embodied conversational agent; smiles;
   human-machine interaction
ID FACIAL EXPRESSIONS; INTERFACE AGENTS; VIRTUAL AGENTS; SMILES; DISPLAYS;
   COMMUNICATION; MACHINE; CONTEXT; GENDER; FALSE
ER

PT J
DE JAK; Janus kinase; Myelofibrosis
ID MYELOPROLIFERATIVE NEOPLASMS; AVAILABLE THERAPY; ESSENTIAL
   THROMBOCYTHEMIA; SURVIVAL; TRANSFORMATION; INHIBITORS; MUTATIONS;
   LEUKEMIA; HEALTH; IMPACT
ER

PT B
DE Conversational Agent; Machine Learning; Ensemble Classifiers; Recurrent
   Neural Networks; Language Modeling
ER

PT S
DE ALICE; chatterbot; conversational agent; mobile assisted language
   learning; m-learning
ER

PT S
DE Process-oriented case-based reasoning; Workflow retrieval;
   Conversational case-based reasoning; Workflows
ID MANAGEMENT; WORKFLOWS; CBR
ER

PT S
DE Willingness to communicate in L2; Conversational agents; Communication
   strategies; Affective backchannels; Intelligent tutoring
ER

PT S
DE Recurrent neural networks; Long short-term memory; Chatbot;
   Conversational agent
ER

PT S
DE Conversational interfaces; Multi-agent systems; Human agent interaction;
   Spoken interaction; Statistical methodologies
ID SYSTEM
ER

PT S
DE human-robot interaction; conversational interface; natural language
   processing; Battle Management Language
ID GESTURE RECOGNITION; SYSTEMS
ER

PT S
ID VISION
ER

PT S
DE programming by demonstration; end user development; task automation;
   SUGILITE
ER

PT S
ID CONVERSION
ER

PT B
DE Conversation Generation; Deep-Learning; Long Short Term Memory (LSTM);
   Japanese tweets
ER

PT B
DE Automotive User Interfaces; Speech Interaction; Natural Language
   Interfaces; Design Space
ER

PT S
DE conversational interface system; natural language processing
ER

PT B
DE software visualization; conversational interface; interactive
   visualization; chatbot; human computer interaction
ER

PT B
DE embodied conversational agent; virtual agent; physical activity; regular
   exercise; persuasion; Chinese culture; new immigrants; cultural
   adaptation
ID RANDOMIZED CONTROLLED-TRIAL; PHYSICAL-ACTIVITY; TRANSTHEORETICAL MODEL;
   AMERICAN-COLLEGE; SPORTS-MEDICINE; PUBLIC-HEALTH; ADULTS;
   RECOMMENDATION; EXERCISE
ER

PT J
DE Conversational Interfaces; Screen readers; Accessibility; Synthetic
   Speech; Inclusive Design
ID SPEECH
ER

PT J
DE Conversational interfaces; mobile devices; multimodal interaction;
   context-awareness; user adaptation; Android
ID SPOKEN DIALOG SYSTEMS; MANAGEMENT; STRATEGIES; GRAMMARS; DESIGN
ER

PT S
DE automation bias; complacency; conversational interface; human-machine
   interaction; controlled natural language
ER

PT J
ID QUESTION PROMPT LIST; EARLY PALLIATIVE CARE; DECISION-MAKING; PROGNOSTIC
   DISCLOSURE; TREATMENT INTENSITY; MORTALITY SALIENCE; END; PHYSICIAN;
   DISCUSSIONS; PREFERENCES
ER

PT J
DE Authentication; Security; Anonymity and privacy; Impersonation attack;
   Provable security; ProVerif
ID NETWORKS
ER

PT B
DE conversational agents; intelligent personal assistants; multi-party
   conversation; collocated interaction; CSCW
ER

PT S
DE Embodied Conversational Agents; cultural heritage; interactive
   documentary
ER

PT S
DE embodied conversational agents; virtual reality; gaze; orientation
ID GAZE; HEAD; EYE; COORDINATION; DISTANCE
ER

PT B
DE Conversational Search; Information Retrieval; Discourse and Dialogue
ER

PT J
ID GLUCAGON-LIKE PEPTIDE-1; OPEN-LABEL; NAIVE PATIENTS; GLP-1 AGONIST;
   EFFICACY; THERAPY; PIOGLITAZONE; TOLERABILITY; COMBINATION; INHIBITOR
ER

PT J
DE Error detection and correction; User modeling; Spoken dialog systems;
   Human-computer interaction; Conversational interfaces
ID CONVERSATIONAL AGENTS; SIMULATION TECHNIQUE; SPEECH RECOGNITION;
   MANAGEMENT; STRATEGIES; MODEL; SATISFACTION; DEVELOP
ER

PT J
ID HEART RHYTHM ASSOCIATION; ORAL ANTICOAGULANTS; EFFICACY; SAFETY;
   GUIDELINES
ER

PT J
ID ANTITHROMBOTIC THERAPY; DOSE CLOPIDOGREL; REACTIVITY; PRASUGREL;
   INTERVENTION; REVASCULARIZATION; IMPLANTATION; THROMBOSIS; CARDIOLOGY;
   OUTCOMES
ER

PT J
ID SEVERE EOSINOPHILIC ASTHMA; IL-13; EXACERBATIONS; EXPRESSION;
   PHENOTYPES; LUNG; CORTICOSTEROIDS; SUBPHENOTYPES; MEPOLIZUMAB;
   ACTIVATION
ER

PT J
ID JUVENILE IDIOPATHIC ARTHRITIS; OCULAR INFLAMMATORY DISORDERS;
   NECROSIS-FACTOR INHIBITORS; REFRACTORY UVEITIS; RHEUMATOID-ARTHRITIS;
   POSTERIOR UVEITIS; CLINICAL-TRIALS; EXPERT PANEL; DISEASE; INFLIXIMAB
ER

PT J
DE Natural language interfaces; Virtual assistants; Embodied conversational
   agents; Multi-agent systems; Semantic grammars; Ontologies
ID NATURAL-LANGUAGE INTERFACES; KNOWLEDGE BASES; WEB; INFORMATION; ENGLISH;
   AGENT; STATE
ER

PT J
ID TYROSINE KINASE INHIBITORS; ACTIVATING MUTATIONS; CHEMOTHERAPY;
   ERLOTINIB; METAANALYSIS; ADENOCARCINOMA; RESISTANCE; MULTICENTER;
   THERAPY; NSCLC
ER

PT J
DE Common ground; Conversational repair; Echoborg; Human-agent interaction;
   Intersubjectivity; Psychological benchmarks
ID HUMAN-ROBOT INTERACTION; INTERFACE AGENTS; ORGANIZATION; BENCHMARKS;
   COMPUTERS; DISCOURSE; MACHINES; SCIENCE; SELF
ER

PT J
ID SOFT-TISSUE SARCOMA; DOUBLE-BLIND; MESYLATE; GEMCITABINE; ANTHRACYCLINE;
   CHEMOTHERAPY; IFOSFAMIDE; DOCETAXEL; PAZOPANIB
ER

PT J
DE Gerontechnology; Assistive technologies and devices; Mental health;
   Multimodal conversational agents; Mobile devices; Android
ID SPOKEN DIALOG SYSTEMS; AUTOMATIC SPEECH RECOGNITION; COUNSELING SYSTEM;
   PHYSICAL-ACTIVITY; DESIGN; MANAGEMENT; ENVIRONMENTS; GENERATION;
   DIAGNOSIS; PROGNOSIS
ER

PT J
ID GENE-RELATED PEPTIDE; BLOOD-BRAIN-BARRIER; CGRP RECEPTOR ANTAGONISTS;
   MONOCLONAL-ANTIBODY; HEALTHY-SUBJECTS; TRIGEMINOVASCULAR SYSTEM;
   RHESUS-MONKEY; TOLERABILITY; TELCAGEPANT; LOCALIZATION
ER

PT J
DE Beverages; Health literacy; Behavioral research; Randomized controlled
   trial; Rural population
ID RE-AIM FRAMEWORK; PLANNED BEHAVIOR; PHYSICAL-ACTIVITY; CLINICAL-TRIAL;
   UNITED-STATES; WEIGHT-GAIN; CONSUMPTION; ADULTS; OBESITY; QUESTIONNAIRE
ER

PT J
ID SARCOPLASMIC-RETICULUM CA2+-ATPASE; ADVANCED HEART-FAILURE;
   MYOCARDIAL-FUNCTION; EXPRESSION; DELIVERY; MODEL
ER

PT J
ID III TRIAL; CHEMOTHERAPY; BEVACIZUMAB; CARBOPLATIN; COMBINATION;
   MONOTHERAPY; PACLITAXEL; GROWTH
ER

PT J
ID MUTATIONS; SUNITINIB
ER

PT J
ID CONTROLLED TRIAL; MANAGEMENT
ER

PT J
ER

PT J
DE Persistent psychotic experiences; need for care; psychosis;
   hallucinations; first-rank symptoms; psychosocial functioning; social
   adversity; childhood trauma; protective factors
ID AUDITORY VERBAL HALLUCINATIONS; GENERAL-POPULATION; PSYCHOMETRIC
   PROPERTIES; ANOMALOUS EXPERIENCES; CHILDHOOD TRAUMA; RISK;
   SCHIZOPHRENIA; SYMPTOMS; SEEKING; MODEL
ER

PT J
ID ECZEMA AREA; PREVALENCE; GUIDELINES; INDEX; MANAGEMENT; CHILDREN;
   ASTHMA; CARE; RELIABILITY; SYMPTOMS
ER

PT J
DE Conversational interfaces; VoiceXML; Mobile devices; Android
ID SPOKEN DIALOG SYSTEMS; SIMULATION TECHNIQUE; AGENTS
ER

PT J
DE Human-machine interaction; Conversational Interfaces; Dialog Management
ID STRATEGIES; SYSTEM
ER

PT J
DE User modeling; Conversational Interfaces; Human-Machine Interaction
ID SPOKEN DIALOG SYSTEMS; MANAGEMENT; STRATEGIES
ER

PT B
DE keyboard; mouse; or touchscreen [1]
ER

PT S
DE Virtual agents; Conversational style; Human-computer interaction; Social
   psychology; Interpersonal attraction; Similarity attraction
ID INTERPERSONAL-ATTRACTION; PERSONALITY; SIMILARITY
ER

PT S
DE Linguistic alignment; Second language acquisition; Virtual agent; Robot;
   Speech output; Nonverbal behavior; Embodiment; Experimental study
ID ANTHROPOMORPHISM; DIALOGUE
ER

PT S
DE Autism spectrum disorder; Conversational virtual agent; Communication
   skills training
ER

PT S
DE voice control system; UAV; the semantic identification of the voice
   commands; voice recognition; MFCC
ER

PT S
DE Laughter; Humor; Social bonding; Evolution; Context
ID EVOLUTION; STRANGERS; INTIMACY; SIZE
ER

PT B
DE Spoken Retrieval; Search Result Summarization; Conversational Search;
   Voice Search; Interactive Information Retrieval
ID SYSTEMS
ER

PT S
DE Interactive speech synthesis; Human-machine-interaction; Conversational
   engagement; Laughter; Interactional entropy; Intrusive machines
ER

PT B
DE Conversational Agents; mental models; evaluation; H.5.m. Information
   interfaces and presentation (e.g., HCI): Miscellaneous
ER

PT S
DE Ontologies; Controlled Natural Language; Conversational Interaction;
   Sensor / Mission Matching; OWL
ER

PT S
DE Human-agent interaction; User interfaces; Conversational agents; Spoken
   and multimodal interaction; Mobile devices; Android
ID AGENTS
ER

PT S
ER

PT J
ID DIALOGUE MANAGEMENT; SYSTEM; SPEECH; RECOGNITION; INFORMATION;
   STRATEGIES; FEATURES; DESIGN
ER

PT J
DE embodied conversational agent; search user interface; information
   retrieval user interface; Web search; health literacy; relational agent;
   computer literacy; search engine; Internet
ID CLINICAL-TRIALS; OF-LIFE; LITERACY; SEARCH; IMPACT; USABILITY; OUTCOMES;
   ADULTS; STYLE
ER

PT J
DE Human - computer dialogue; Syntactic alignment; Speech interaction; User
   behaviour; Psycholinguistics; Interlocutor modelling
ID LANGUAGE PRODUCTION; COORDINATION; ACQUISITION; PERSISTENCE; MACHINES;
   SPEAKERS
ER

PT J
ID TRANSIENT ELASTOGRAPHY; DIALYSIS PATIENTS; RANDOMIZED-TRIAL; LIVER
   FIBROSIS; RENAL-DISEASE; RIBAVIRIN; CIRRHOSIS; MK-5172; HCV;
   TRANSPLANTATION
ER

PT J
ID CLINICAL-PRACTICE GUIDELINES; LIVER-TRANSPLANTATION; RISK-FACTORS;
   RECURRENCE; PREVENTION; THERAPY; CANCER; ANGIOGENESIS; PERSPECTIVES;
   MANAGEMENT
ER

PT J
DE Speech dialog system; Driving simulation study; Usability; Driver
   distraction
ER

PT J
ID GROWTH-FACTOR RECEPTOR; PROTEIN EXPRESSION; PLUS GEMCITABINE; EGFR
   MUTATIONS; CANCER NSCLC; CHEMOTHERAPY; CISPLATIN; SURVIVAL;
   ADENOCARCINOMA; HISTOLOGY
ER

PT J
DE Collaborative Conversational Recommenders; Intelligent Collaborative 3D
   Interface; 3D Virtual Worlds
ID VIRTUAL WORLDS; ENVIRONMENTS
ER

PT J
ID GLUCAGON-LIKE PEPTIDE-1; BASAL-BOLUS REGIMEN; PLUS ORAL-AGENTS;
   TO-TARGET TRIAL; DOUBLE-BLIND; RECEPTOR AGONIST; PARALLEL-GROUP;
   METFORMIN; EFFICACY; LIRAGLUTIDE
ER

PT J
ID GRAM-NEGATIVE BACILLI; UNITED-STATES; TRIMETHOPRIM-SULFAMETHOXAZOLE;
   INTRAVENOUS DORIPENEM; RESISTANCE PATTERNS; ESCHERICHIA-COLI;
   CIPROFLOXACIN; MULTICENTER; PREVALENCE; PREVENTION
ER

PT J
ID ANTI-PD-1 ANTIBODY; RESPONSE CRITERIA; SAFETY; IPILIMUMAB; PD-1; CANCER;
   EXPRESSION; TOLERANCE; LYMPHOMA; BLOCKADE
ER

PT J
ID PULSE-WAVE ANALYSIS; ELECTRONIC SKIN; TRIBOELECTRIC GENERATOR; PRESSURE;
   TRANSISTORS; DESIGN; MATRIX; ELECTRIFICATION; ASSEMBLIES; NETWORKS
ER

PT J
ID DENSITY-LIPOPROTEIN CHOLESTEROL; AMG 145; MONOCLONAL-ANTIBODY; LDL-C;
   RECEPTOR GENE; OPEN-LABEL; EFFICACY; ATORVASTATIN; SIMVASTATIN;
   REDUCTION
ER

PT B
DE mobile multimodal; usability; conversational interface; elderly
ER

PT S
DE Natural Language Interface to Databases (NLIDB); Conversational Agents
   (CA); Knowledge base; Artificial Intelligence (AI); Pattern Matching
   (PM)
ER

PT B
DE Embodied conversational agents; assistive technologies; attention
   estimation; dementia
ID ELDERLY-PEOPLE; AVATARS
ER

PT B
ER

PT B
ID NATURAL-LANGUAGE INTERFACES; WEB; PERFORMANCE; INFORMATION; ONTOLOGIES
ER

PT S
DE Agent simulation; User modeling; Conversational agents; Human machine
   interfaces; Spoken interaction
ID SIMULATION
ER

PT S
DE engagement; common ground; subjective experience; empathy; mind-reading
   display
ID ONLINE DISINHIBITION
ER

PT S
DE Sample Selection; Imbalanced data; Clustering; Human-Machine interfaces;
   Conversational agents; Spoken interaction
ID CLASSIFIERS
ER

PT S
DE Conversational agents; Spoken interaction; User modeling; Emotion
   recognition; Adaptation
ID DIALOGUE SYSTEMS; SPEECH RECOGNITION; INFORMATION
ER

PT S
DE Conversational Interfaces; Dialog Systems; Emotion Recognition;
   E-therapy; Adaptation; Spoken Interaction; Mobile Interfaces
ID SPEECH RECOGNITION; DIALOG SYSTEMS; INFORMATION; FEATURES
ER

PT S
DE Assistive technology; Cognitive impairment; Conversational agents
ID SPEECH RECOGNITION; SEVERE DYSARTHRIA; SPEAKERS
ER

PT S
ID TURN-TAKING
ER

PT S
DE Design methodologies; Evaluation methodologies and user studies;
   Applications for film, animation, art and games; Cyranoid; Echoborg
ID SHADOWED SPEECH; IMPRESSION; ACCESS
ER

PT S
DE Human-agent interaction; User interfaces; Conversational agents; Spoken
   and multimodal interaction; Mobile devices; Android
ID AGENTS
ER

PT S
DE Conversational Agents; Digital Libraries; Assistants; Multimodal
   Interaction; Spoken Interaction; Mobile Devices; Android
ER

PT S
DE Natural conversational interaction; mixed-reality; multi-modal dialogue
   systems; immersive; debate skills; learning analytics; reflection
ER

PT J
DE Natural Language Processing; Dialog System; Conversational Agent;
   Academic Advising; Advising System; Engineering Education; E-learning;
   Human Computer Interaction
ER

PT J
DE Microalgae; Biofuels; Production cost; Economics; Microalgal biorefinery
ID PIGGERY WASTE-WATER; BIODIESEL PRODUCTION; CHLORELLA-ZOFINGIENSIS;
   ALGAE; CULTIVATION; BIOFUELS; ENERGY; FEEDSTOCKS; CHALLENGES; ECONOMICS
ER

PT B
ER

PT J
DE Apology; Social Response To Computer; Synthetic Voice; Voice Gender; VUI
ER

PT J
DE bipolar illness; connectivity; resting state; schizophrenia; thalamus
ID TRANSCRANIAL MAGNETIC STIMULATION; INTRINSIC FUNCTIONAL CONNECTIVITY;
   HUMAN BRAIN; WORKING-MEMORY; BASAL GANGLIA; STRUCTURAL CONNECTIVITY;
   HALLUCINATED VOICES; PREDICTION-ERROR; PATTERN-ANALYSIS; HUMAN THALAMUS
ER

PT J
ID SOMATOSTATIN ANALOGS; GROWTH-HORMONE; MULTICENTER; THERAPY; LAR; SOM230;
   SAFETY; HYPERGLYCEMIA; TOLERABILITY; PEGVISOMANT
ER

PT J
ID FLUTICASONE PROPIONATE/SALMETEROL 250/50; GEORGE RESPIRATORY
   QUESTIONNAIRE; SHORT-TERM RESPONSE; CONTROLLED-TRIAL; CORTICOSTEROID
   TREATMENT; AIRWAY EOSINOPHILIA; COPD EXACERBATIONS; CHRONIC-BRONCHITIS;
   ASTHMA; INFLAMMATION
ER

PT J
ID PEPTIDE-1 RECEPTOR AGONISTS; DAILY LIVING QUESTIONNAIRE; GATEKEEPING
   PROCEDURES; PHYSICAL-ACTIVITIES; ANALOG LIRAGLUTIDE; GLYCEMIC CONTROL;
   PARALLEL-GROUP; EXENATIDE; EFFICACY; SAFETY
ER

PT J
ID IMMUNOGENICITY; RECOMBINANT; GUIDELINES
ER

PT J
ID MALIGNANT GLIOMA; INTEGRIN ALPHA(V)BETA(3); RECURRENT GLIOBLASTOMA;
   CLINICAL-TRIAL; UNITED-STATES; TEMOZOLOMIDE; RADIOTHERAPY; EXPRESSION;
   BRAIN; BEVACIZUMAB
ER

PT J
ID III TRIAL; CHEMOTHERAPY; BEVACIZUMAB; CARBOPLATIN; PACLITAXEL; SURVIVAL;
   ERLOTINIB; TUMORS; LIFE
ER

PT J
ID PLACEBO-CONTROLLED TRIAL; ADHERENCE; MULTICENTER; DISABILITY; EFFICACY;
   THERAPY; DEGENERATION; PATHOGENESIS; DELIVERY; DRUG
ER

PT J
ID COMPUTER-MEDIATED COMMUNICATION; NONVERBAL BEHAVIOR; INTERPERSONAL
   DECEPTION; TRUSTWORTHINESS; DESIGN; CONSTRUCTION; CREDIBILITY;
   DOMINANCE; INTERFACE; SCALE
ER

PT J
DE Social Attitude; Natural Interaction; Ambient Conversational Systems;
   Embodied Conversational Agents
ID HUMAN-COMPUTER INTERACTION; EMOTION RECOGNITION; BODY GESTURES;
   EXPRESSIONS; AUDIO; CUES
ER

PT J
ER

PT J
ID III TRIAL; FOLLOW-UP; SAFETY; EFFICACY; OUTCOMES; BG-12
ER

PT J
ID HIV PREVENTION; MICROBICIDE ACCEPTABILITY; TREATMENT ADHERENCE;
   CLINICAL-TRIAL; GEL; INTERVENTION; MOTIVATION; ZIMBABWE; SUPPORT;
   BARRIER
ER

PT J
DE Human-computer interface; Intelligent tutoring systems; Interactive
   learning environments; Teaching/learning strategies
ID LEARNING STYLES; EDUCATIONAL-SYSTEM; COGNITIVE-STYLE; USER-INTERFACE;
   CLASSIFICATION; RECOMMENDATION; DIAGNOSIS; INTERACT
ER

PT J
DE Decoupling; flexure mechanisms; long stroke; micro-/nanopositioning;
   motion control; parallel mechanisms
ID STAGE; IDENTIFICATION; MANIPULATION; MECHANISM; MOTION
ER

PT J
ID MODIFYING ANTIRHEUMATIC DRUGS; RECEIVING CONCOMITANT METHOTREXATE;
   DIFFERENT TREATMENT STRATEGIES; COMBINATION THERAPY; AMERICAN-COLLEGE;
   CLINICAL-TRIALS; RADIOGRAPHIC PROGRESSION; MONOCLONAL-ANTIBODY; TIGHT
   CONTROL; DOUBLE-BLIND
ER

PT J
ID ENDOTHELIAL GROWTH-FACTOR; HYPOXIA-INDUCIBLE FACTOR-1-ALPHA;
   CLINICOPATHOLOGICAL SIGNIFICANCE; MICROVESSEL DENSITY; TUMOR
   ANGIOGENESIS; SUPPORTIVE CARE; CLINICAL-TRIALS; FACTOR RECEPTOR; CANCER;
   EXPRESSION
ER

PT S
DE Conversational agent; speech interfaces; TTS; ASR; chatbot; question
   answering; multilingual information systems; AIML; Latvian
ER

PT S
DE conversational interface; intelligence; surveillance; reconnaissance;
   controlled natural language
ER

PT S
DE Dialog systems; Multimodal interaction; Android; Mobile devices; User
   adaptation; Statistical methodologies
ID CONVERSATIONAL AGENTS; SIMULATION TECHNIQUE
ER

PT J
ID EMBODIED CONVERSATIONAL AGENTS; MARKUP LANGUAGE; PERSUASION; EXPRESSION;
   ENGINE; SYSTEM
ER

PT B
ID SYSTEM
ER

PT B
DE dynamic serious games; adapdable environments; embodies conversational
   agents; virtual humans; interactive virtual environments
ER

PT B
ER

PT J
DE mHealth; low- and middle-income countries; health systems;
   interventions; mobile data
ID RESOURCE-LIMITED SETTINGS; RANDOMIZED CONTROLLED-TRIAL; MOBILE PHONES;
   HEALTH-WORKERS; DATA-COLLECTION; RURAL UGANDA; CARE; COMMUNICATION;
   GUIDELINES; ATTENDANCE
ER

PT J
DE immunization; health communication; preventive health services
ID SHARED DECISION-MAKING; HESITANT PARENTS; CHILDHOOD VACCINES;
   UNITED-STATES; PRIMARY-CARE; IMMUNIZATION; PHYSICIANS; ATTITUDES;
   CHILDREN; PEDIATRICIANS
ER

PT J
ID USER SIMULATION; SYSTEMS; STRATEGIES; DESIGN
ER

PT J
ID SUBEROYLANILIDE HYDROXAMIC ACID; HISTONE DEACETYLASE INHIBITOR; PHASE-I;
   CANCER; CARFILZOMIB; PROTEASOME; TRIAL
ER

PT J
ID COTRANSPORTER 2 INHIBITOR; GLYCEMIC CONTROL; ADD-ON; MELLITUS;
   MONOTHERAPY; DAPAGLIFLOZIN; WEIGHT; SULFONYLUREAS; GLIPIZIDE; INSULIN
ER

PT J
DE Virtual humans; Social networking sites; Human-virtual human
   interaction; Dialogue
ER

PT J
DE Automatic affect detection; Affective spoken dialog system; Domestic
   environment; HiFi agent; Social intelligence; Dialog features;
   Conversational cues; User bias; Predicting user satisfaction
ID AFFECTIVE SPEECH; EMOTION; ANNOTATION; LANGUAGE; TUTORS; CUES
ER

PT J
ID INTERLEUKIN-12/23 MONOCLONAL-ANTIBODY; RHEUMATOID-ARTHRITIS;
   DISEASE-ACTIVITY; CLINICAL-FEATURES; EUROPEAN LEAGUE; RECOMMENDATIONS;
   INFLAMMATION; IMPROVEMENT; VALIDATION; MANAGEMENT
ER

PT J
ID DISABILITY STATUS SCALE; T-CELLS; ACTIVATION; ANTIBODY; THERAPY; EDSS
ER

PT J
DE Affective interfaces; conversational avatars; mobile devices; text
   messaging; user experience; user modeling
ER

PT J
ID MODIFYING ANTIRHEUMATIC DRUGS; DISEASE-ACTIVITY; EULAR RECOMMENDATIONS;
   DOUBLE-BLIND; FUNCTIONAL-CAPACITY; REMISSION; THERAPY; RA; MANAGEMENT;
   DAMAGE
ER

PT J
DE Multimodality corpus; Conversational involvement; Spontaneous speech
ID NONVERBAL INVOLVEMENT; DIALOGUE; SYSTEMS
ER

PT J
ER

PT J
ID TYROSINE KINASE INHIBITOR; ADJUVANT IMATINIB; GROWTH-FACTOR; IN-VIVO;
   RESISTANCE; KIT; MUTATIONS; MECHANISMS; MESYLATE; SU11248
ER

PT J
ID GLYCEMIC CONTROL; RECEPTOR AGONISTS; TREATED PATIENTS; PARALLEL-GROUP;
   METFORMIN; EFFICACY; SAFETY; TRIAL; EXENDIN-4; SULFONYLUREA
ER

PT S
DE Conversational Interface; Chatbot; Ontology; AIML
ER

PT S
DE non-task oriented conversational agent; log analysis; virtual
   philosopher
ER

PT B
DE Facial Expression Analysis; Sequence Modeling; Human Computer
   Interaction
ER

PT S
DE 3D human pose; conversational interaction classification; interaction
   analysis; Kinect sensor
ID MOTION CAPTURE; RECOGNITION; REPRESENTATION
ER

PT B
ID USER
ER

PT S
DE spoken language understanding; domain detection; conversational systems;
   multi-party conversations
ER

PT S
DE Controlled English; ISR; decision support; analyst; intelligence;
   conversational interaction; conversational interface; mobile app;
   CE-SAM; sensor mission assignment; resource allocation
ID DISTRIBUTED SENSOR NETWORK; TASK ALLOCATION; NODE SELECTION;
   LOCALIZATION; ASSIGNMENT; MEDICINE; SYSTEMS
ER

PT J
DE Conversational agents; user simulation; statistical methodologies;
   multiagent systems
ID SPOKEN DIALOG SYSTEMS; USER SIMULATION; DESIGN; PERSPECTIVE; STRATEGIES
ER

PT B
ID SPEECH RECOGNITION
ER

PT J
ID ARQ 197; SOLID TUMORS; SORAFENIB; TRIAL; MET; SUBANALYSES; INHIBITOR;
   EFFICACY; THERAPY; SAFETY
ER

PT S
DE evaluation; anthropomorphic interfaces; user centered design
ER

PT J
DE Conversational systems; Incremental processing; Speech generation;
   Wizard-of-Oz
ID PROSODY; REPAIRS
ER

PT J
ID LOW-DENSITY-LIPOPROTEIN; CORONARY-HEART-DISEASE; FAMILIAL
   HYPERCHOLESTEROLEMIA; LDL CHOLESTEROL; PCSK9; THERAPY; GUIDELINES; TRIAL
ER

PT J
ID MONOCLONAL-ANTIBODY TREATMENT; LYMPHOCYTE DEPLETION; INTERFERON-BETA;
   CLINICAL-TRIAL; FUNCTIONAL COMPOSITE; OUTCOME MEASURE; RECONSTITUTION;
   CAMPATH-1H; TESTS
ER

PT J
ID ALL-CAUSE MORTALITY; GLYCEMIC CONTROL; GLUCOSE CONTROL;
   CARDIOVASCULAR-DISEASE; ADD-ON; METAANALYSIS; MELLITUS; RISK;
   HYPOGLYCEMIA; ASSOCIATION
ER

PT J
DE Dialogue; Speech acts; Conversational Agents; Natural Language
   Generation
ID EMBODIED CONVERSATIONAL AGENT
ER

PT J
DE symptoms; psychosis; hallucinosis; research; domain; criteria; auditory
   network; model
ID VERBAL HALLUCINATIONS; VISUAL HALLUCINATIONS; INTRUSIVE THOUGHTS;
   SPEECH-PERCEPTION; HEARING VOICES; PSYCHOSIS; INDIVIDUALS; DISORDER;
   REALITY; SIMILARITIES
ER

PT J
DE antiretrovirals; biomedical HIV prevention trials; microbicide;
   pre-exposure prophylaxis
ID TENOFOVIR DISOPROXIL FUMARATE; SIMPLEX-VIRUS TYPE-2; HORMONAL
   CONTRACEPTIVES; ANTIRETROVIRAL THERAPY; IN-VITRO; INFECTION; WOMEN;
   PHARMACOKINETICS; TRANSMISSION; MICROBICIDE
ER

PT J
ID OPT-80; EPIDEMIOLOGY; ANTIBIOTICS; DIARRHEA; SOCIETY; DISEASE
ER

PT J
DE Conversational context; Nonverbal behavior; Brainstorming;
   Decision-making; CSCW; Social inference machines
ID GROUP-DYNAMICS; MEETINGS; BEHAVIOR; CORPUS
ER

PT J
ID SKELETAL-RELATED EVENTS; OSTEOPROTEGERIN LIGAND; ANDROGEN DEPRIVATION;
   ZOLEDRONIC ACID; BREAST-CANCER; COMPLICATIONS; ACTIVATION; DISEASE
ER

PT B
DE Artificial companions; Conversational agents; Human-machine
   relationship; Long-term interaction
ID MULTICOMPETENCE
ER

PT B
DE Conversational Interfaces; Crowdsourcing
ER

PT B
DE Android; embedded conversational agent; dialogue strategy; focus tree;
   mobile phone
ER

PT B
DE Unconcious; non-intrusive interfaces; nonverbal cue; cup-shaped device
ID EXPERIENCE
ER

PT J
DE Speech recognition; Lexical access; Adverse conditions; Signal
   degradation; Cognitive load; Masking
ID SPOKEN-WORD RECOGNITION; PRECATEGORICAL ACOUSTIC STORAGE;
   TIME-COMPRESSED SPEECH; VERBAL WORKING-MEMORY; CONVERSATIONAL SPEECH;
   LANGUAGE COMPREHENSION; SENTENCE COMPREHENSION; INDIVIDUAL-DIFFERENCES;
   INFORMATIONAL MASKING; LISTENING CONDITIONS
ER

PT S
DE Emotional model and dynamics; facial expressions
ID AGENT
ER

PT S
DE Human Computer Interface; Spoken Dialogue System; Language Model Design;
   Online Services
ER

PT J
ID PROGRESSION-FREE SURVIVAL; PROGNOSTIC-FACTORS; CANCER-THERAPY;
   NEOPLASMS; PATHWAY; AGENTS; AKT
ER

PT J
ID RHEUMATOID-ARTHRITIS; ORAL FINGOLIMOD; B-CELLS; CEREBROSPINAL-FLUID;
   DOUBLE-BLIND; T-CELLS; RITUXIMAB; EFFICACY; ANTIBODY; DISEASE
ER

PT J
DE Parkinson's disease; evidence-based medicine; levodopa; dopamine
   agonists; monoamine oxidase inhibitors; catechol-O-methyl transferase
   inhibitors; amantadine; anticholinergics; clozapine; neurosurgery; deep
   brain stimulation; exercise; physical therapy; speech therapy;
   occupational therapy; acupuncture
ID RANDOMIZED CONTROLLED-TRIAL; DEEP-BRAIN-STIMULATION; SUBTHALAMIC NUCLEUS
   STIMULATION; QUALITY-OF-LIFE; 24-HOUR PROLONGED RELEASE;
   LEVODOPA-TREATED PATIENTS; IMPULSE CONTROL DISORDERS; PLACEBO-CONTROLLED
   TRIAL; VOICE TREATMENT LSVT(R); DOUBLE-BLIND
ER

PT J
ER

PT J
DE Dialogue; Universal access; Conversational system; Conversational
   interface
ID LANGUAGE; AGENTS
ER

PT J
ID GROWTH-FACTOR RECEPTOR; TYROSINE KINASE INHIBITOR; MONOCLONAL-ANTIBODY;
   ANTITUMOR-ACTIVITY; COMBINATION; MUTATIONS; GEFITINIB; CARBOPLATIN;
   PACLITAXEL; THERAPY
ER

PT J
ID EFFICACY; ALCOHOL; ABSTINENT
ER

PT J
DE Companions; Embodied conversational agents; Conversational spoken
   dialogue systems; Mobile interfaces; Cognitive modelling; Dialogue
   management
ID SYSTEMS
ER

PT J
ID CONTROLLED PHASE-II; BREAST-CANCER; SKELETAL COMPLICATIONS;
   CONTROLLED-TRIALS; LONG-TERM; THERAPY; MULTICENTER; PREVENTION;
   CARCINOMA; SURVIVAL
ER

PT J
DE Conversational robot; Conversational agent; Robot intelligence; Behavior
   and dialogue control; Multi-expert model
ID SYSTEMS
ER

PT J
ID TO-TARGET TRIAL; GLUCOSE-LOWERING DRUGS; GLYCEMIC CONTROL; ORAL-THERAPY;
   COMBINATION THERAPY; PARALLEL-GROUP; NAIVE PEOPLE; NPH INSULIN;
   OPEN-LABEL; ADD-ON
ER

PT S
ER

PT S
DE Embodied Conversational Agent; Human-Computer Interaction; User
   Interface
ER

PT S
ER

PT S
DE Human Interaction; Nonverbal Communication; Virtual Communication;
   Enhanced Interaction; Virtual Audience
ID SPEECH
ER

PT S
DE Embodied Conversational Agent; Implicit Association Test
ID ASSOCIATION TEST
ER

PT S
DE Embodied conversational agent; multimodal interface; audio-video
   recording; autism; children's speech
ER

PT J
DE Ontology; personal assistant agents; intelligent assistance; semantic
   analysis; conversational interfaces; multi-agent systems
ID INTERFACE; SYSTEMS
ER

PT J
DE Collaborative learning; intelligent agents; natural language interfaces;
   software architectures
ID TUTORING SYSTEM; DIALOGUE
ER

PT S
DE Game design; computational thinking; debugging; end-user programming;
   visual programming
ER

PT J
ID GENDER-EQUITY ISSUES; EXTRA-ROLE BEHAVIORS; PROACTIVE BEHAVIOR;
   HIERARCHICAL ORGANIZATIONS; PERSONAL CONTROL; SELLING ISSUES;
   CROSS-LEVEL; WORK; COMMUNICATION; SILENCE
ER

PT S
DE Information Extraction; Knowledge Trees; Conversational Agents;
   Conversation-Based Interfaces to Relational Databases
ER

PT B
DE Embodied Conversational Agents; Acceptability; Companion robot;
   Emotions; and personality
ID INFORMATION-TECHNOLOGY; USER ACCEPTANCE
ER

PT B
DE Dialogue model; Reasoning model; Conversational agent; Information
   state; Update rules
ER

PT S
DE Social interface; Conversational workload; Minimalism designing
ER

PT J
DE HCI; conversational systems; evaluation methodology
ID ECONOMIC DECISION-MAKING; LANGUAGE DIALOGUE; HUMOR; COMMUNICATION;
   RECOGNITION; INFORMATION; EMOTIONS; EXCHANGE; SPEECH; EEG
ER

PT J
DE Gricean maxims; Flouting; Particularized conversational implicature;
   Cognitive principles; Pragmatic marking; Cognitive marking
ID IMPLICATURE
ER

PT J
DE ECA; Behavior; Multimodal; Distinctive; Expressive
ER

PT J
DE Embodied conversational agents; Non-verbal communication; Robustness;
   Comparative evaluation; Spoken dialogue system; Voice authentication;
   Speaker verification; Gesture design
ER

PT J
ID METASTATIC BREAST-CANCER; ADVANCED ESOPHAGOGASTRIC CANCER; ADJUVANT
   CHEMOTHERAPY; GENE AMPLIFICATION; 1ST-LINE THERAPY; SUPPORTIVE CARE; III
   TRIAL; PLUS; HER2; FLUOROURACIL
ER

PT J
ID SERUM URIC-ACID; SGLT2 INHIBITOR; METABOLIC SYNDROME; CLINICAL-TRIALS;
   RISK-FACTORS; MELLITUS; THERAPY; ASSOCIATION; MONOTHERAPY; ADJUSTMENT
ER

PT J
ID CISPLATIN PLUS GEMCITABINE; III TRIAL; CHEMOTHERAPY; THERAPY;
   CARBOPLATIN; PACLITAXEL; BEVACIZUMAB; COMBINATION; INSTITUTE; DURATION
ER

PT J
DE iPod (TM); Driving simulator; Distraction; Eye movement; Attention;
   Music retrieval systems
ID DRIVING SIMULATOR; RISK AWARENESS; EXPERIENCE; DRIVERS
ER

PT J
ID PITTSBURGH COMPOUND-B; CEREBROSPINAL-FLUID; FOLLOW-UP; CLINICAL-TRIALS;
   RATING-SCALE; BRAIN; IMMUNIZATION; BINDING; PROTEIN; PATHOLOGY
ER

PT J
ID DENSITY-LIPOPROTEIN CHOLESTEROL; TRIGLYCERIDE TRANSFER PROTEIN;
   CORONARY-HEART-DISEASE; LIVER-DISEASE; ANTISENSE; SIMVASTATIN; STATINS;
   EZETIMIBE; APHERESIS; EFFICACY
ER

PT J
ID APRIL-AUGUST 2009; UNITED-STATES; VIRUS; IMMUNOGENICITY; TRANSMISSION;
   PATHOGENESIS; INFECTION; FERRETS; ADULTS
ER

PT B
ER

PT S
DE Intelligent Tutoring System; Conversational Agent; Learning Style
ID STUDENTS; DIALOGUE
ER

PT J
ID ANIMATED PEDAGOGICAL AGENTS; PART I; ENVIRONMENTS; DESIGN; RECOGNITION;
   EDUCATION; LANGUAGE; FEATURES; SCIENCE; MODELS
ER

PT S
DE Multimodal interfaces; verbal communication; stress; cognitive load;
   physiological measurements; qualitative evaluations
ER

PT B
DE Expert system; Conversational agent; Knowledge engineering; Knowledge
   tree; Bullying; Harassment
ER

PT B
DE Interactive Genetic Programming; Conversational Agent; Evolutionary
   Algorithm; Dialogue System; Natural Language Generation
ID LANGUAGE GENERATION
ER

PT S
DE Virtual humans; embodied agents; display comparison; medical education;
   immersive virtual environments
ER

PT S
ID FEEDBACK
ER

PT S
DE Embodied Conversational Agents; Companion; Affective Dialogue;
   Conversational Dialogue; Interruptions; Interaction Strategies
ID FEEDBACK
ER

PT S
DE Virtual Humans; Intelligent Agent Authoring Tools; motivational
   strategies; persuasive technology; virtual patients; leaderboards;
   narratives; deadlines
ER

PT B
DE Human Robot Interaction; Intuitive Interface; Biomimetic Sensing;
   Robotic Flower; Smart Home
ER

PT J
ID RELATIONAL AGENTS; WORKING ALLIANCE; ADULTS; INTERVENTIONS; PROGRAM;
   IMPACT
ER

PT J
ID TREATMENT-NAIVE PATIENTS; INTEGRASE INHIBITOR RALTEGRAVIR; SOCIETY-USA
   PANEL; COMBINATION THERAPY; ANTIRETROVIRAL THERAPY; DAILY
   LOPINAVIR/RITONAVIR; MYOCARDIAL-INFARCTION; 2008 RECOMMENDATIONS;
   SAFETY; EFFICACY
ER

PT J
DE Academic libraries; Public libraries; Canada; Intelligent agents; User
   interfaces; Information retrieval
ER

PT S
DE Service robots; Interactive robots; Mass collaboration; User interface
ER

PT S
DE visual analytics; natural language processing; conversational interface;
   automatic visualization
ER

PT S
DE Metaphor; affect detection; context and character profiles
ER

PT J
ID ACUTE CORONARY SYNDROMES; GLYCOPROTEIN IIB/IIIA BLOCKADE;
   CLINICAL-OUTCOMES; BLOOD-TRANSFUSION; ACUITY TRIAL; ANTIPLATELET
   THERAPY; IMPACT; ABCIXIMAB; INTERVENTION; RISK
ER

PT J
ID INTEGRASE INHIBITOR RALTEGRAVIR; ANTIRETROVIRAL DRUG-RESISTANCE;
   NEUROPSYCHIATRIC ADVERSE EVENTS; SOCIETY-USA PANEL; 2008
   RECOMMENDATIONS; PHASE-II; PREVALENCE; TRANSMISSION; REPLICATION;
   NEVIRAPINE
ER

PT J
ID RENAL VASODILATION; CONSCIOUS RATS; PREGNANCY HORMONE; CLINICAL-TRIALS;
   PEPTIDE; HYPERFILTRATION; HEMODYNAMICS; ANTAGONIST; ENDOTHELIN;
   TEZOSENTAN
ER

PT J
DE cellular phone; SMS; text messaging; wireless; outcomes of care; process
   of care
ID RANDOMIZED CONTROLLED-TRIAL; SHORT-MESSAGE SERVICE; TYPE-2
   DIABETIC-PATIENTS; PHYSICAL-ACTIVITY; MOBILE PHONES; TEXT; INTERVENTION;
   TECHNOLOGY; TELEPHONE; INTERNET
ER

PT J
ID COLLAGEN-INDUCED ARTHRITIS; RHEUMATOID-ARTHRITIS; JOINT DESTRUCTION;
   EFFICACY; SAFETY; INFLAMMATION; ADALIMUMAB; THERAPY; DISEASE; IL-17
ER

PT J
ID ORAL ANTIPLATELET THERAPY; DRUG-ELUTING STENTS; PLATELET INHIBITION;
   UNCOATED STENTS; ASPIRIN; ANGIOPLASTY; TICLOPIDINE; ABCIXIMAB; DISEASE;
   SAFETY
ER

PT S
DE dialog systems; artificial intelligence; human-computer interaction;
   software evaluation
ER

PT B
ID ECONOMICS; FINANCE
ER

PT S
DE NLP; Dialogue Systems; Telemedicine; Hypertension
ER

PT S
DE telephony control; Lithuanian voice commands recognition
ER

PT S
DE Speech; Spoken Dialog Interface; Usability; Usability Evaluation;
   Auditory User Interface; Human Computer Interaction; Accessibility;
   Computer Mediated Communication
ID PARADISE
ER

PT S
DE Multimodal Corpora; Embodied Conversational Agents; Cultural Usability
ID NONVERBAL BEHAVIOR
ER

PT S
DE Embodied Conversational Agents; Cultural Heuristics; Multimodal
   Interaction
ID ENGAGEMENT
ER

PT S
ER

PT S
DE Synthetic interview; Physics Pathway; physics pedagogy; physics
   education
ER

PT S
ID 2ND LIFE
ER

PT S
DE Virtual Humans; Agents and Intelligent Systems; Human-centered
   Computing; Distributed Knowledge Acquisition; End-user Programming
ER

PT S
ER

PT S
ER

PT S
ER

PT J
DE Personal Assistants; Embodied Conversational Assistants; CSCW;
   Ontologies
ID GROUPWARE; SYSTEM
ER

PT J
ID OVER-EXPRESSION; NATURAL-HISTORY; CANCER; EPIDEMIOLOGY; GUIDELINES;
   THERAPIES; PROGNOSIS; CIRRHOSIS; TUMORS; JAPAN
ER

PT S
ID ADAPTATION; LANGUAGE; ALGEBRA
ER

PT J
DE embodied conversational agents; innovative research methods; evaluation;
   embodiment; human-technology-interaction
ID VIRTUAL ENVIRONMENTS; NONVERBAL BEHAVIOR; INTERFACE AGENTS; PERCEPTION
ER

PT J
ID EYE-MOVEMENTS; LISTENERS
ER

PT J
DE creativity; evaluation; interface design; user behaviour; music
ID INPUT DEVICES
ER

PT J
ID ADVANCED SOLID TUMORS; MAMMALIAN TARGET; CLINICAL-TRIALS;
   INTERFERON-ALPHA; KIDNEY CANCER; INHIBITOR; PATHWAYS; ONCOLOGY; MTOR
ER

PT J
DE multimodality; autism; design; animated conversational agent; facial
   expression; training
ID ASPERGER-SYNDROME; EXECUTIVE DYSFUNCTION; NORMAL-CHILDREN; ADULTS;
   VOCABULARY
ER

PT J
ID CONTINUOUS INTRAVENOUS EPOPROSTENOL; BRAIN NATRIURETIC PEPTIDE;
   PLACEBO-CONTROLLED TRIAL; PROSTACYCLIN ANALOG; INHALED ILOPROST;
   THERAPY; SURVIVAL; DISEASE; SITAXSENTAN; SILDENAFIL
ER

PT J
ID CYTOKINE; IL23R; SKIN; KERATINOCYTES; PATHOGENESIS; ASSOCIATION;
   DERMATOLOGY; EXPRESSION; THERAPIES; DISORDER
ER

PT J
ID PLAQUE PSORIASIS; PATHOGENESIS; THERAPY; IL-12
ER

PT J
ID RECEIVING CONCOMITANT METHOTREXATE; CARDIOVASCULAR RISK-FACTORS;
   COLLEGE-OF-RHEUMATOLOGY; ACUTE-PHASE REACTANTS; LIPID PROFILE;
   MONOCLONAL-ANTIBODY; INFLIXIMAB THERAPY; ACTIVITY SCORE; DISEASE;
   VALIDATION
ER

PT S
DE Dialogue systems; formal language theory; grammar systems
ER

PT B
ER

PT S
ID MODEL
ER

PT S
DE natural language processing; humor; jokes; Japanese puns; pun generator;
   non-task oriented conversational system
ER

PT B
DE Speech interface; dialog systems; assistant agents; ontology;
   conversational interfaces
ER

PT B
ER

PT B
DE Automatic processing of social media; discourse analysis
ER

PT S
DE Affordances; Conversational Interactions; Multimodal QA systems;
   Usability Inspection; Cognitive Walkthrough
ID DESIGN
ER

PT S
DE emotional and social interaction; situated cognition; embodied
   conversational agents; virtual therapy
ER

PT B
DE H.5.2 [information interfaces and presentation]: user interfaces;
   interaction styles; 1.3.6 [computer graphics]: methodology and
   techniques; interaction techniques
ER

PT B
DE conversational systems; natural language interface; user interface;
   semantic web; ontology; email
ER

PT S
DE Conversational engagement; eye-gaze; conversational agents
ER

PT S
ER

PT B
DE spoken dialogue systems; multimodality; software architectures; physical
   agent interfaces
ID SYSTEMS; ARCHITECTURE
ER

PT S
DE theory of mind; embodied conversational agents;
   human-computer-interaction; perspective taking; common ground
ID CONVERSATIONAL AGENTS; PERSPECTIVE-TAKING; REPRESENTATIONS; KNOWLEDGE;
   INTERFACE; IMITATION; OTHERS; SELF
ER

PT S
ER

PT S
ER

PT B
DE personal assistants; animated agents; CSCW; knowledge management;
   ontology
ER

PT B
DE eye tracking; embodied conversational agents; Second Life
ER

PT J
ID COLLAGEN
ER

PT J
DE visual feedback; head gesture recognition; contextual information;
   context-based recognition
ID DISCOURSE
ER

PT J
DE Embodied conversational agent; Distributed system; User interface;
   Non-verbal interaction
ER

PT J
ID PERSPECTIVE-TAKING; INDIRECT REPLIES; COMPREHENSION; PREFERENCE;
   KNOWLEDGE; COMMUNICATION; ORGANIZATION; TEXT
ER

PT B
DE spoken dialogue systems; multi-layer architectures; conversational
   interfaces
ER

PT B
DE Spoken dialog system; assistive robotics
ER

PT B
DE Enhanced TV; Interactive TV; Conversational Avatars; Active Ageing;
   Ambient Assisted Living; Elderly People; Cognitively Impaired People
ER

PT B
DE embodied conversational agent; distributed system; blackboard; user
   interface; Croatian speech recognition; Croatian speech synthesis
ER

PT S
ER

PT J
DE conversational agents; pattern matching; semantic Bayesian networks;
   user interface; mixed-initiative interaction
ER

PT S
ER

PT S
ER

PT S
ER

PT S
ER

PT S
DE conversational systerns; Natural Language Interface; semantic web;
   ontology; email
ER

PT B
ER

PT B
DE conversational interfaces; intelligent interfaces; kiosk; RFID; embodied
   conversational agent (ECA); information systems
ER

PT B
DE Recommender systems; example-critiquing interfaces; personalized search
ER

PT S
ER

PT S
DE in-car systems; emotion recognition; emotional responses; driving
   simulator; affective computing; speech recognition
ER

PT S
ID DIALOGUE; LANGUAGE
ER

PT S
DE interruption; disruption; recovery; conversation; cognitive models
ER

PT S
DE conversational agents; natural language; SQL
ER

PT J
DE spoken dialogue system; personal medical advisor; prescription
   compliance; artificial intelligence
ER

PT J
DE chatterbots; conversational agents; domestic appliances; natural
   language interfaces; smart house; servants; Turing test
ER

PT J
ER

PT J
DE recommender systems; collaborative recommendations; diversity
ER

PT B
ER

PT S
DE embodied conversational agents; talking faces; audiovisual speech
   synthesis; face-to-face interaction
ID SOCIAL ATTENTION; PERCEPTION; DIRECTION; EYES; MIND
ER

PT S
ER

PT J
DE Personal Advisor; Embodied Conversational Agents; M-learning;
   Multiagent-Systems; Virtual Universities
ID AGENTS
ER

PT S
ER

PT B
DE Natural Language Processing (NLP); Artificial Intelligence (AI);
   question answering (QA) system; embodied conversational agent (ECA)
ER

PT S
ID CONVERSATION
ER

PT B
DE dialog systems; cognitive load; robustness
ER

PT B
DE Spoken dialog management; voice user interface design; natural language
   understanding; technical support problem resolution; discourse analysis
ER

PT J
ID EXPRESSIONS
ER

PT S
DE interactive digital storytelling; authoring; transition graph;
   conversational storytelling; visualization of dialogues
ER

PT J
DE embodied conversational agents; multi-party communication
ER

PT J
ER

PT B
DE facial animation; usability analysis
ER

PT S
ER

PT S
ER

PT B
DE conversational interaction; spoken dialogue systems
ER

PT J
DE intelligent tutoring systems; spoken dialogue; reflective tutoring;
   multimodality; speech technology
ER

PT S
ID SUPPORT-SYSTEMS; GIS; CARTOGRAPHY
ER

PT S
ER

PT S
ER

PT S
ER

PT S
ER

PT S
ID INTERFACE AGENTS; COMPUTERS
ER

PT B
ER

PT S
ID INFORMATION
ER

PT B
DE knowledge visualization; persistence; conversations; conversational
   tools; social visualization
ID MANAGEMENT
ER

PT B
DE speech interface; ontology; personal assistants
ER

PT S
ID REALITY; ENVIRONMENTS
ER

PT S
ER

PT S
ER

PT S
ER

PT J
DE virtual humans; embodied conversational agents; ambient intelligence;
   smart environments; virtual reality
ER

PT J
ER

PT J
DE facial animation; embodied conversational agents
ID COMMUNICATION; EXPRESSIONS; INTONATION; MOVEMENT; LANGUAGE; SPEECH
ER

PT B
ER

PT B
DE about four key words or phrases in alphabetical order; separated by
   commas
ER

PT J
DE spoken language processing; voice-active robot; conversational
   interface; human-robot conversation; social robots
ID SPEECH RECOGNITION
ER

PT S
ID QUESTIONS; AGENTS; ASKING
ER

PT S
ER

PT S
ER

PT J
ER

PT S
ER

PT B
ID TECHNOLOGY; SUPPORT
ER

PT B
DE embodied conversational agents; design; evaluation framework;
   methodology
ID INTERFACE; FEEDBACK
ER

PT B
DE children's speech; animated software characters; conversational
   interfaces; text-to-speech; audio interface design; science education;
   educational software
ID PERSONALITY; STUDENTS
ER

PT B
DE conversational agents; evaluation; eCommerce.
ER

PT S
ER

PT S
ER

PT S
ER

PT S
DE conversational agents; speech interaction; mobile applications of
   artificial intelligence
ER

PT S
ER

PT J
DE dialogue; embodied conversational agent; small talk; social interface;
   trust
ER

PT S
ER

PT S
ID AGENTS
ER

PT B
ER

PT B
ER

PT S
ER

PT B
ID AUGMENTED REALITY
ER

PT S
ER

PT J
ID SIDE-BY-SIDE; COORDINATION; FOCUS; WORK
ER

PT B
DE conversations; discussions; electronic mail; email; information
   visualization; threads; tree structures; user interfaces
ER

PT S
ER

PT S
ER

PT S
ER

PT B
ID RESPONSES
ER

PT S
DE embodied conversational agent; chatterbot; affective computing;
   visualization
ER

PT S
ER

PT S
ER

PT S
ID MODELS; USERS
ER

PT B
DE sign language; lip reading; gesture; morphing; conversational interfaces
ER

PT J
DE natural language; dialog; speech recognition; multilingual
   conversational
ER

PT J
DE eye movement synthesis; facial animation; statistical modeling;
   saccades; HCI (Human-Computer Interface)
ER

PT J
DE human factors; dialogue management; human computer interaction; language
   generation; language understanding; speech recognition; speech synthesis
ID TO-SPEECH TECHNIQUES; HUMAN-MACHINE; RECOGNITION; SYSTEM; TEXT;
   SUBDIALOGUES; GENERATION; MODEL
ER

PT J
DE automatic speech recognition for children; computer games;
   conversational agents; human-computer interaction; multimedia
   interfaces; multimodal systems; spoken dialogue systems
ID SPEECH; INFORMATION; SYSTEM
ER

PT B
ER

PT B
ER

PT B
ER

PT S
ER

PT B
ER

PT S
ER

PT B
DE conversation; human-computer interaction; symbolic modeling; artificial
   intelligence; computer games
ER

PT J
ID FEEDBACK; AGENTS
ER

PT J
ID FEEDBACK; GESTURES; HAND
ER

PT J
ID REALITY
ER

PT J
DE avatars; anthropomorphic interfaces; conversational interfaces; facial
   animation; behavioral animation
ER

PT J
DE Rea; embodied interface agent; communicative behavior; embodied
   conversational agent
ID AGENTS
ER

PT S
ID APPRAISAL
ER

PT J
ER

PT J
ER

PT J
ER

PT J
DE conversational interfaces; speech understanding systems; spoken dialogue
   systems
ID SYSTEM
ER

PT J
ER

PT J
ER

PT S
DE multimodal conversational agents; personal service assistants;
   human-computer interface; multi-agent systems
ER

PT J
DE conversational interfaces; dialogue systems; speech understanding;
   telephone-based speech recognition
ID SYSTEM
ER

PT S
ER

PT J
ER

PT S
ER

PT S
ER

EF